{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:03:14Z","timestamp":1789970594265,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["Qiankehezhicheng [2020]4Y146"],"award-info":[{"award-number":["Qiankehezhicheng [2020]4Y146"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05119-7","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:25:58Z","timestamp":1784777158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of twice-daily 0.01% atropine combined with Orthokeratology versus DIMS lenses in myopia control: an elastic net penalized regression analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Guoli","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peimi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"5","key":"5119_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342.","journal-title":"Ophthalmology"},{"issue":"3","key":"5119_CR2","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"5119_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, Chen H, Wu G, Ohno-Matsui K, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond). 2019;33(1):3\u201313.","journal-title":"Eye (Lond)"},{"issue":"1","key":"5119_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","volume":"20","author":"C Zhao","year":"2020","unstructured":"Zhao C, Cai C, Ding Q, Dai H. Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis. BMC Ophthalmol. 2020;20(1):478.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"5119_CR5","first-page":"205","volume":"34","author":"NA McBrien","year":"1993","unstructured":"McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci. 1993;34(1):205\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5119_CR6","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1167\/iovs.06-1051","volume":"48","author":"JA Rada","year":"2007","unstructured":"Rada JA, Palmer L. Choroidal regulation of scleral glycosaminoglycan synthesis during recovery from induced myopia. Invest Ophthalmol Vis Sci. 2007;48(7):2957\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5119_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, et al. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology. 2020;127(7):910\u20139.","journal-title":"Ophthalmology"},{"issue":"11","key":"5119_CR8","first-page":"1535","volume":"104","author":"A Fu","year":"2020","unstructured":"Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K, et al. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol. 2020;104(11):1535\u201341.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"5119_CR9","doi-asserted-by":"publisher","first-page":"22267","DOI":"10.1038\/s41598-021-01708-2","volume":"11","author":"C Cui","year":"2021","unstructured":"Cui C, Li X, Lyu Y, Wei L, Zhao B, Yu S, et al. Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial. Sci Rep. 2021;11(1):22267.","journal-title":"Sci Rep"},{"issue":"2","key":"5119_CR10","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1111\/aos.15235","volume":"101","author":"S Wei","year":"2023","unstructured":"Wei S, Li SM, An W, Du J, Liang X, Sun Y, et al. Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial. Acta Ophthalmol. 2023;101(2):e177\u201384.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"5119_CR11","first-page":"P1","volume":"130","author":"DS Jacobs","year":"2023","unstructured":"Jacobs DS, Afshari NA, Bishop RJ, Keenan JD, Lee J, Shen TT, et al. Refractive Errors Preferred Pract Pattern\u00ae Ophthalmol. 2023;130(3):P1\u201360.","journal-title":"Refractive Errors Preferred Pract Pattern\u00ae Ophthalmol"},{"issue":"2","key":"5119_CR12","first-page":"Cd014758","volume":"2","author":"JG Lawrenson","year":"2025","unstructured":"Lawrenson JG, Huntjens B, Virgili G, Ng S, Dhakal R, Downie LE, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2025;2(2):Cd014758.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"5119_CR13","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5119_CR14","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","volume":"53","author":"T Hiraoka","year":"2012","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53(7):3913\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5119_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"5119_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022;140(5):472\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"5119_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1167\/iovs.61.5.53","volume":"61","author":"HY Zhang","year":"2020","unstructured":"Zhang HY, Lam CSY, Tang WC, Leung M, To CH. Defocus Incorporated Multiple Segments Spectacle Lenses Changed the Relative Peripheral Refraction: A 2-Year Randomized Clinical Trial. Invest Ophthalmol Vis Sci. 2020;61(5):53.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5119_CR18","doi-asserted-by":"publisher","first-page":"100923","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"5119_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/j.1538-9235.1993.tb03109.x","volume":"70","author":"RL Terry","year":"1993","unstructured":"Terry RL, Schnider CM, Holden BA, Cornish R, Grant T, Sweeney D, et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci. 1993;70(3):234\u201343.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"5119_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"2","key":"5119_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361.","journal-title":"Pharm Stat"},{"issue":"4","key":"5119_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"key":"5119_CR23","doi-asserted-by":"crossref","unstructured":"Xu S, Wang M, Qu Y, Wang Y, Jiang J, Zhou F, et al. Twice-daily administration improves the effectiveness of 0.01% atropine for controlling myopia in slowing axial elongation and refractive progression. Ophthalmic Physiol Opt. 2025.","DOI":"10.1111\/opo.13558"},{"issue":"5","key":"5119_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng AL, Choy BN, Cheng GP, Woo VC, Cho P. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt. 2020;40(5):557\u201366.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"5119_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12886-022-02635-0","volume":"22","author":"S Yu","year":"2022","unstructured":"Yu S, Du L, Ji N, Li B, Pang X, Li X, et al. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial. BMC Ophthalmol. 2022;22(1):438.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"5119_CR26","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","volume":"10","author":"N Kinoshita","year":"2020","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, et al. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep. 2020;10(1):12750.","journal-title":"Sci Rep"},{"issue":"1","key":"5119_CR27","doi-asserted-by":"publisher","first-page":"12356","DOI":"10.1038\/s41598-025-91089-7","volume":"15","author":"CY Lee","year":"2025","unstructured":"Lee CY, Yang SF, Chang YL, Huang JY, Lian IB, Chang CK. The effect of defocus incorporated multiple segment spectacles\u2019 lenses combined with different concentrations atropine for myopia control. Sci Rep. 2025;15(1):12356.","journal-title":"Sci Rep"},{"issue":"1","key":"5119_CR28","doi-asserted-by":"publisher","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang Z, Chen XF, He T, Tang Y, Du CX. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12(1):22311.","journal-title":"Sci Rep"},{"issue":"9","key":"5119_CR29","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","volume":"38","author":"T Tang","year":"2024","unstructured":"Tang T, Lu Y, Li X, Zhao H, Wang K, Li Y, et al. Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Eye (Lond). 2024;38(9):1660\u20137.","journal-title":"Eye (Lond)"},{"issue":"1","key":"5119_CR30","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.clae.2024.102317","volume":"48","author":"X Cao","year":"2025","unstructured":"Cao X, Guo Z, Wei Z, Ming H, Ma B, Zhao Y, et al. Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children. Cont Lens Anterior Eye. 2025;48(1):102317.","journal-title":"Cont Lens Anterior Eye"},{"issue":"11","key":"5119_CR31","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/OPX.0b013e31826c1831","volume":"89","author":"Z Chen","year":"2012","unstructured":"Chen Z, Niu L, Xue F, Qu X, Zhou Z, Zhou X, et al. Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci. 2012;89(11):1636\u201340.","journal-title":"Optom Vis Sci"},{"issue":"2","key":"5119_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.61.2.22","volume":"61","author":"JK Lau","year":"2020","unstructured":"Lau JK, Vincent SJ, Cheung SW, Cho P. Higher-Order Aberrations and Axial Elongation in Myopic Children Treated With Orthokeratology. Invest Ophthalmol Vis Sci. 2020;61(2):22.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5119_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/08164622.2022.2140031","volume":"106","author":"J P\u00e9rez-Corral","year":"2023","unstructured":"P\u00e9rez-Corral J, Cardona G, Pi\u00f1ero DP, Barroso D, Armadans L. Short- and mid-term changes in CORVIS ST parameters in successful, adult orthokeratology patients. Clin Exp Optom. 2023;106(7):726\u201333.","journal-title":"Clin Exp Optom"},{"key":"5119_CR34","doi-asserted-by":"crossref","unstructured":"Zhu X, McBrien NA, Smith EL 3rd, Troilo D, Wallman J. Eyes in various species can shorten to compensate for myopic defocus. Invest Ophthalmol Vis Sci. 2013;54(4):2634\u201344.","DOI":"10.1167\/iovs.12-10514"},{"issue":"2","key":"5119_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s40123-023-00671-7","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, Jiang Y, Zhu Z, Zhang S, Xuan M, Tan X, et al. Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. Ophthalmol therapy. 2023;12(2):1223\u201337.","journal-title":"Ophthalmol therapy"},{"issue":"8","key":"5119_CR36","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1167\/iovs.09-3460","volume":"50","author":"L Shelton","year":"2009","unstructured":"Shelton L, Rada JA. Inhibition of human scleral fibroblast cell attachment to collagen type I by TGFBIp. Invest Ophthalmol Vis Sci. 2009;50(8):3542\u201352.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5119_CR37","doi-asserted-by":"publisher","first-page":"110214","DOI":"10.1016\/j.exer.2024.110214","volume":"251","author":"D Che","year":"2025","unstructured":"Che D, Qiao D, Lv L, Zhang Y, Cao Y, Li F, et al. Effects of atropine on choroidal hemodynamics and VEGFA and HIF-1\u03b1 expression in form-deprivation myopia guinea pigs. Exp Eye Res. 2025;251:110214.","journal-title":"Exp Eye Res"},{"issue":"7","key":"5119_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.7150\/ijms.93643","volume":"21","author":"CY Lee","year":"2024","unstructured":"Lee CY, Yang SF, Chang YL, Huang JY, Lian IB, Chang CK. Comparison of myopic control between orthokeratology contact lenses and defocus incorporated multiple segments spectacle lenses. Int J Med Sci. 2024;21(7):1329\u201336.","journal-title":"Int J Med Sci"},{"issue":"10","key":"5119_CR39","first-page":"549","volume":"77","author":"SM Saw","year":"2000","unstructured":"Saw SM, Nieto FJ, Katz J, Schein OD, Levy B, Chew SJ. Factors related to the progression of myopia in Singaporean children. Optom Vis Sci. 2000;77(10):549\u201354.","journal-title":"Optom Vis Sci"},{"issue":"7","key":"5119_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archopht.123.7.977","volume":"123","author":"L Hyman","year":"2005","unstructured":"Hyman L, Gwiazda J, Hussein M, Norton TT, Wang Y, Marsh-Tootle W, et al. Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the correction of myopia evaluation trial. Arch Ophthalmol. 2005;123(7):977\u201387.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"5119_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41433-021-01923-1","volume":"37","author":"J Tian","year":"2023","unstructured":"Tian J, Wei S, Li S, An W, Bai W, Liang X, et al. The effect of atropine 0.01% eyedrops on relative peripheral refraction in myopic children. Eye (Lond). 2023;37(2):356\u201361.","journal-title":"Eye (Lond)"},{"key":"5119_CR42","doi-asserted-by":"publisher","first-page":"859944","DOI":"10.3389\/fped.2022.859944","volume":"10","author":"J Mu","year":"2022","unstructured":"Mu J, Zeng D, Fan J, Liu M, Zhong H, Shuai X, et al. The accuracy of the axial length and axial length\/corneal radius ratio for myopia assessment among Chinese children. Front Pediatr. 2022;10:859944.","journal-title":"Front Pediatr"},{"issue":"10","key":"5119_CR43","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.4103\/njcp.njcp_183_16","volume":"20","author":"SA Badmus","year":"2017","unstructured":"Badmus SA, Ajaiyeoba AI, Adegbehingbe BO, Onakpoya OH, Adeoye AO. Axial length\/corneal radius of curvature ratio and refractive status in an adult Nigerian population. Niger J Clin Pract. 2017;20(10):1328\u201334.","journal-title":"Niger J Clin Pract"},{"issue":"7","key":"5119_CR44","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/opo.70036","volume":"45","author":"L Chong","year":"2025","unstructured":"Chong L, Zhu Y, Bi H, Lin W, Gu T, Li N, et al. Axial length to corneal curvature ratio moderates the effect of corneal reshaping on axial growth in orthokeratology. Ophthalmic Physiol Opt. 2025;45(7):1981\u20138.","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05119-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:52:40Z","timestamp":1789969960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05119-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5119"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05119-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study (No. 2025-S101) was provided by the Ethics Committee of the First People\u2019s Hospital of Guiyang, Guiyang, China, on 30 July 2025. Because this research involved the retrospective analysis of anonymized, pre-existing clinical data, the requirement for informed consent to participate was formally waived by the Ethics Committee of the First People\u2019s Hospital of Guiyang. All clinical investigations have been conducted according to the principles expressed in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"585"}}